Innovation

For Impact

At Dana-Farber, we push the boundaries of scientific discovery, bringing transformative technologies to those affected by cancer and related diseases worldwide. Our innovations expand our understanding of biology in health and disease and advance diagnosis, treatment, cure, and prevention towards a world free of the fear and burden of cancer.

Latest in Technologies

Explore the rapid technological advances made in the laboratories at Dana-Farber. Take a deep dive into understanding each innovation and the benefits it may offer to patients and their families.

Covalent Inhibitors Against VCPIP1, a Deubiquitinating Enzyme with Critical Roles in Pancreatic Adenocarcinoma and Botulinum Neurotoxin Intoxication

Collaboration

CDK7 Inhibitors and Degraders for Treatment of Cancer and Inflammatory Diseases

Licensing

Monoclonal Antibodies Targeting TIM-3 to Block Binding to the Human TIM-3 Receptor

Licensing

Enhancing Cytotoxic T Lymphocytes for Cellular Therapy in Acute Myeloid Leukemia

Licensing

More Technologies

A mission that guides us. The state of the art technology that fuels us. The people who question, create, and imagine what might be possible. This is innovation at Dana-Farber.